Obesity has emerged as one of the most pressing public health challenges of our time, affecting millions worldwide and transcending traditional concerns about physical appearance. This chronic ...

Recently, an international commission proposed a revised definition of obesity that focuses on how excess body fat affects the body, and factors in waist circumference, rather than simply ...

The proposed recommendations, endorsed by more than 75 medical organisations around the world, are designed to address limitations in the traditional definition and diagnosis of obesity that ...

Jan. 27, 2025 — A study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future ... Signposting Children to ...

The rising prevalence of childhood obesity, especially post-Covid 19 pandemic, has emerged as a significant health concern. With prolonged periods of inactivity during lockdowns and increased ...

The buzz around biotech IPOs is continuing through January, with clinical-stage metabolic company Aardvark Therapeutics revealing plans to go public while Hong Kong-listed Ascentage Pharma joins ...

This result, if confirmed in larger trials, could give the medicine an edge over available obesity treatments.

Dr. Rajan explained, "If you think obesity is just about willpower, you don't fully understand this complex metabolic condition." He went on to clarify, "What Oprah is referring to here is called ...

The phase 1b/2a study compared the GLP-1 and amylin receptor agonist to placebo in 125 people who are overweight or with obesity. Patients achieved an estimated weight loss of 9.7% on 1.25 mg ...

Europe's largest pharmaceutical firm, Novo Nordisk, revealed positive trial results for its next-generation obesity drug, amycretin, marking a major step in its competition within the increasingly ...

Novo Nordisk shares rose sharply Friday after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial. Shares were 7 ...